Business Description
Kura Oncology Inc
NAICS : 325414
SIC : 2836
ISIN : US50127T1097
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 31.06 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -7 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | -7.9 | |||||
3-Year Book Growth Rate | -16.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.6 | |||||
9-Day RSI | 60 | |||||
14-Day RSI | 58.2 | |||||
6-1 Month Momentum % | 86.07 | |||||
12-1 Month Momentum % | 35.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.67 | |||||
Quick Ratio | 16.67 | |||||
Cash Ratio | 16.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -14.51 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -38.43 | |||||
ROA % | -35.06 | |||||
ROIC % | -802.72 | |||||
ROC (Joel Greenblatt) % | -2217.45 | |||||
ROCE % | -36.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.28 | |||||
Price-to-Tangible-Book | 3.28 | |||||
EV-to-EBIT | -7.06 | |||||
EV-to-Forward-EBIT | -5.26 | |||||
EV-to-EBITDA | -7.1 | |||||
EV-to-Forward-EBITDA | -5.26 | |||||
EV-to-Forward-Revenue | 10.12 | |||||
EV-to-FCF | -8.58 | |||||
Price-to-Net-Current-Asset-Value | 3.39 | |||||
Price-to-Net-Cash | 3.47 | |||||
Earnings Yield (Greenblatt) % | -14.16 | |||||
FCF Yield % | -8.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kura Oncology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -2.005 | ||
Beta | -0.27 | ||
Volatility % | 84.3 | ||
14-Day RSI | 58.2 | ||
14-Day ATR (€) | 0.501158 | ||
20-Day SMA (€) | 18.8295 | ||
12-1 Month Momentum % | 35.25 | ||
52-Week Range (€) | 7 - 21.8 | ||
Shares Outstanding (Mil) | 76.18 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kura Oncology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kura Oncology Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Kura Oncology Inc Frequently Asked Questions
What is Kura Oncology Inc(STU:KUR)'s stock price today?
When is next earnings date of Kura Oncology Inc(STU:KUR)?
Does Kura Oncology Inc(STU:KUR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |